| |
Use your personal checklist to remind you about the tools and resources we offer.
|
|
|
|
| |
WRAP UP THE YEAR WITH CONFIDENCE
With a new year approaching, take a moment to remind yourself about our tools and resources that can support your commitment to therapy.
Your personal checklist
|
Call Shared Solutions® at 1-800-887-8100 to
|
| |
|
|
|
| |
|
Understand and navigate through the confusing process of choosing or changing health plans and coverage with our help
|
| |
| |
|
Investigate your insurance and benefits, and find out if your co-pay could be lower
|
| |
| |
|
Receive a free 2015 Printed Planner
|
| |
| |
|
Order your free COPAXONE® (glatiramer acetate injection) Travel Kit
|
| |
|
|
Check out www.COPAXONE.com to
|
| |
| |
|
See our Community section for local events and teleconferences, and to find out about the MS Peer* program
|
| |
| |
|
Meet Claire, your Virtual Health Assistant (VHA), and get instant information about COPAXONE® and MS
|
| |
| |
|
Access the COPAXONE webTracker™ on your desktop to help you stay on track with your therapy and manage your injection schedule
|
| |
|
|
Visit the App Store℠ or Google Play to
|
| |
| |
|
Download the COPAXONE iTracker® to help you manage your injections on the go
|
| |
| |
|
|
| |
| |
*Peers with relapsing forms of MS. MS Peers are compensated by Teva.
|
| |
|
|
| |
| |
As 2014 comes to an end, take a moment to learn about the financial services that can help you maintain access to COPAXONE® in the new year.
|
| |
| |
| |
If eligible, your co-pay for daily COPAXONE® 20 mg could be lowered to $35 per month out of pocket† with COPAXONE Co-pay Solutions®.
Did you know that with 3-times-a-week COPAXONE® 40 mg, if you are eligible, your co-pay could be lowered to $0 per month out of pocket‡?
|
|
| |
| |
| |
Call Shared Solutions® at 1-800-887-8100 to learn more.
|
| |
|
|
|
| |
COPAXONE® is indicated for the treatment of patients with relapsing forms of multiple sclerosis.
Important Safety Information
Do not take COPAXONE® if you are allergic to glatiramer acetate or mannitol.
Some patients report a short-term reaction right after injecting COPAXONE®. This reaction can involve flushing (feeling of warmth and/or redness), chest tightness or pain with heart palpitations, anxiety, and trouble breathing. These symptoms generally appear within minutes of an injection, last about 15 minutes, and do not require specific treatment. During the postmarketing period, there have been reports of patients with similar symptoms who received emergency medical care. If symptoms become severe, call the emergency phone number in your area. Call your doctor right away if you develop hives, skin rash with irritation, dizziness, sweating, chest pain, trouble breathing, or severe pain at the injection site. If any of the above occurs, do not give yourself any more injections until your doctor tells you to begin again.
Chest pain may occur either as part of the immediate postinjection reaction or on its own. This pain should only last a few minutes. You may experience more than one such episode, usually beginning at least one month after starting treatment. Tell your doctor if you experience chest pain that lasts for a long time or feels very intense.
A permanent indentation under the skin (lipoatrophy or, rarely, necrosis) at the injection site may occur, due to local destruction of fat tissue. Be sure to follow proper injection technique and inform your doctor of any skin changes.
The most common side effects in studies of COPAXONE® are redness, pain, swelling, itching, or a lump at the site of injection, flushing, rash, shortness of breath, and chest pain. These are not all of the possible side effects of COPAXONE®. For a complete list, ask your doctor or pharmacist. Tell your doctor about any side effects you have while taking COPAXONE®.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Please see full Prescribing Information.
|
†
|
Applies only to daily COPAXONE® 20 mg. Certain limits and restrictions apply.
Terms and Conditions for daily COPAXONE® 20 mg include: COPAXONE Co-pay Solutions® is open to both new and existing patients who are residents of the US or Puerto Rico and who have commercial prescription insurance coverage for COPAXONE® 20 mg. The offer is not valid for patients covered in whole or in part by Medicaid, Medicare, TRICARE, or any other federal or state government pharmaceutical assistance plan or program (regardless of whether a specific prescription is covered), or by private health benefit programs that reimburse for the entire cost of prescription drugs. Use of this offer must be consistent with the terms of any drug benefit provided by a health insurer, health plan, or private third-party payor. This offer is void where prohibited by law, taxed, or restricted. No additional purchase is required. This offer is valid only at participating pharmacies and may be changed or discontinued at any time without notice. This program is not health insurance.
|
|
‡
|
Applies only to 3-times-a-week COPAXONE® 40 mg. Certain limits and restrictions apply.
Terms and Conditions for 3-times-a-week COPAXONE® 40 mg include: COPAXONE Co-pay Solutions® is open to both new and existing patients who are residents of the US or Puerto Rico and who have commercial prescription insurance coverage for COPAXONE® 40 mg. The offer is not valid for uninsured patients or patients covered in whole or in part by Medicaid, Medicare, TRICARE, or any other federal or state government pharmaceutical assistance plan or program (regardless of whether a specific prescription is covered), or by private health benefit programs that reimburse for the entire cost of prescription drugs. Use of this offer must be consistent with the terms of any drug benefit provided by a health insurer, health plan, or private third-party payor. This offer is void where prohibited by law, taxed, or restricted. No additional purchase is required. This offer is valid only at participating pharmacies and may be changed or discontinued at any time without notice. This program is not health insurance.
|
Privacy Notice | One Click Unsubscribe | Terms of Use
|
|
| |
|
|
COPAXONE®, COPAXONE CO-PAY SOLUTIONS®, and COPAXONE iTracker® are registered trademarks of Teva Pharmaceutical Industries Ltd.
Shared Solutions® is a registered service mark of Teva Neuroscience, Inc.
COPAXONE webTracker™ is a trademark of Teva Pharmaceutical Industries Ltd.
Apple, iTunes, and iPhone are trademarks of Apple Inc., registered in the U.S. and other countries.
App Store is a service mark of Apple Inc. Android is a trademark of Google Inc.
Google Play is a trademark of Google Inc.
© 2014 Teva Neuroscience, Inc. COP-42258
Teva Neuroscience, Inc., COPAXONE® Marketing, 11100 Nall Avenue, Overland Park, KS 66211
|
|
|
